Corporate Banner
Satellite Banner
Technology Networks Header
Friday, October 24, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Waters Launches Progenesis QI Version 2.0 for Small Molecule Data Analysis at IMSC 2014
Monday, August 25, 2014
Next Generation Software Offers Enhanced Control and Function, with Pathway Mapping, Process Automation, and Improved Access to Compound Databases.

Shimadzu Announces New i-Series Integrated Liquid Chromatography Systems
Thursday, August 21, 2014
Innovative, intuitive and intelligent functionality advances HPLC for labs of the future.

New Hydrophobic Interaction Column from Thermo Fisher Scientific
Wednesday, August 20, 2014
Laboratories are offered additional selectivity for separating monoclonal antibodies or antibody-drug conjugates.

Simple and Accurate Determination of Total Choline
Friday, August 08, 2014
Total choline determination in infant formulas and adult nutritionals by ion chromatography method.

Determination of Thiosulfate and Pyrophosphate in Crayfish Wash Powder
Tuesday, August 05, 2014
Determination by a simple, efficient, sensitive, and reproducible capillary ion chromatography method.

AB SCIEX Announces the 4500MD Series* for In Vitro Diagnostic Use
Tuesday, July 29, 2014
Industry leader increases mass spectrometry portfolio for clinical testing laboratories.

New Phenomenex GC Column Set for Chlorinated Pesticides
Friday, July 25, 2014
The Zebron ZB-CLPesticides GC column runs seven EPA methods.

Reliable Assays for Sugars in Acid-Hydrolyzed Wood
Friday, July 25, 2014
Determination of common sugars by high-performance anion-exchange chromatography with pulsed amperometric detection methods.

WHEATON® Highlights Products at AACC 2014
Thursday, July 24, 2014
The products to be featured at the meeting offer unique solutions for the clinical market.

<< 1 2 3 4 5 6 7 >>
Showing Results 21 - 30 of 778
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv